10/22/2025 9:05:01 AM GRUR Annual Meeting 2025: A panel discussion on the infringement of patents with use claims, particularly second medical use claims, in the US, UK, UPC and Germany By Dominic Adair This article was first published in Kluwer Patent Blog [October, 2025]. Coinciding with the 100th year anniversary of the German and UK...
10/21/2025 12:57:12 PM Don’t get lost – How femtech can navigate the EU medical device and AI rules By Xisca Borrás Ellie Handy This article was originally published by Femtech World. Femtech, short for female technology, is an important and fast growing sector....
9/4/2025 8:57:18 AM Breaking Resistance – could AI revolutionise antibiotic discovery? By Claire Smith Using generative AI to discover new antibiotics On 14 August 2025, the Massachusetts Institute of Technology (MIT) reported1 that a team...
8/15/2025 3:32:17 PM MHRA announces Early Access Service for Innovative Medical Devices By Hugo Kent-Egan Alex Denoon In another welcome development, the MHRA has published an interesting Statement of Policy Intent for Early Access Service to Innovative...
8/14/2025 11:42:10 AM Women’s healthcare and UK competition enforcement – recent developments By Antonia Kendrick Healthcare generally is a priority enforcement sector for competition watchdogs across the world, including the UK’s Competition and...
8/7/2025 9:15:57 AM From academia to industry: The role of university spin-outs in women’s health innovation By Laura Harwood Melissa Dix University spin-out companies offer a means of commercialising valuable intellectual property (IP) and technology generated through...
8/4/2025 1:40:59 PM Recognition of CE-marked medical devices in the UK By Hugo Kent-Egan Alex Denoon On 22 July 2025, the UK Government signalled that it is likely to pivot back to indefinite recognition of CE Marking of devices. In a...
7/31/2025 8:51:24 AM The double-edged sword of AI in femtech in the EU By Ellie Handy Subhalakshmi Kumar Kiran Sidhu AI presents many opportunities in the women’s health space, but it can also pose considerable risks. Anyone seeking to commercialise...
7/30/2025 3:01:07 PM It’s time to act on the new R&D regime By Julia Cockroft Tabitha Reed Although the UK’s new R&D tax relief regime came into force on 1 April 2024, many companies have only now completed their first...
7/30/2025 2:34:53 PM Biotech Review of the Year: latest developments By Bristows LLP At the start of the year, our editors (Xisca Borrás, Katie Cambrook and Aida Tohala) presented to you the 12th edition of our Biotech...
7/30/2025 10:54:35 AM Sarepta’s Duchenne difficulties: potential implications for gene therapy licensing By Ellen Lambrix Luca Cericola Earlier this year, we reported on key considerations that parties involved in the negotiation and drafting of financial milestone...
7/25/2025 8:54:32 AM Licensing Executives Society Britain & Ireland 2025 Annual Conference: Licensing as a solution in an age of uncertainty By Ellen Lambrix Luca Cericola Earlier this month, Ellen Lambrix and Luca Cericola from Bristows’ Commercial & IP Transactions team attended the Licensing Executives...